Global Antibodies Market Research Report 2023

Report ID: 1977784 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Antibodies Market Overview
    1.1 Product Overview and Scope of Antibodies
    1.2 Antibodies Segment by Type
        1.2.1 Global Antibodies Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Monoclonal antibodies
        1.2.3 Polyclonal antibodies
        1.2.4 Antibody drug conjugates
    1.3 Antibodies Segment by Application
        1.3.1 Global Antibodies Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Long-term care facilities
        1.3.4 Research institutes
    1.4 Global Antibodies Market Size Estimates and Forecasts
        1.4.1 Global Antibodies Revenue 2017-2028
        1.4.2 Global Antibodies Sales 2017-2028
        1.4.3 Antibodies Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antibodies Market Competition by Manufacturers
    2.1 Global Antibodies Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Antibodies Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Antibodies Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Antibodies Manufacturing Sites, Area Served, Product Type
    2.5 Antibodies Market Competitive Situation and Trends
        2.5.1 Antibodies Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Antibodies Players Market Share by Revenue
        2.5.3 Global Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibodies Retrospective Market Scenario by Region
    3.1 Global Antibodies Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Antibodies Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Antibodies Market Facts & Figures by Country
        3.3.1 North America Antibodies Sales by Country
        3.3.2 North America Antibodies Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Antibodies Market Facts & Figures by Country
        3.4.1 Europe Antibodies Sales by Country
        3.4.2 Europe Antibodies Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Antibodies Market Facts & Figures by Region
        3.5.1 Asia Pacific Antibodies Sales by Region
        3.5.2 Asia Pacific Antibodies Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Antibodies Market Facts & Figures by Country
        3.6.1 Latin America Antibodies Sales by Country
        3.6.2 Latin America Antibodies Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Antibodies Market Facts & Figures by Country
        3.7.1 Middle East and Africa Antibodies Sales by Country
        3.7.2 Middle East and Africa Antibodies Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Antibodies Historic Market Analysis by Type
    4.1 Global Antibodies Sales Market Share by Type (2017-2022)
    4.2 Global Antibodies Revenue Market Share by Type (2017-2022)
    4.3 Global Antibodies Price by Type (2017-2022)
5 Global Antibodies Historic Market Analysis by Application
    5.1 Global Antibodies Sales Market Share by Application (2017-2022)
    5.2 Global Antibodies Revenue Market Share by Application (2017-2022)
    5.3 Global Antibodies Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Novartis
        6.1.1 Novartis Corporation Information
        6.1.2 Novartis Description and Business Overview
        6.1.3 Novartis Antibodies Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Novartis Antibodies Product Portfolio
        6.1.5 Novartis Recent Developments/Updates
    6.2 F. Hoffmann-La Roche
        6.2.1 F. Hoffmann-La Roche Corporation Information
        6.2.2 F. Hoffmann-La Roche Description and Business Overview
        6.2.3 F. Hoffmann-La Roche Antibodies Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 F. Hoffmann-La Roche Antibodies Product Portfolio
        6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
    6.3 Johnson & Johnson Services
        6.3.1 Johnson & Johnson Services Corporation Information
        6.3.2 Johnson & Johnson Services Description and Business Overview
        6.3.3 Johnson & Johnson Services Antibodies Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Johnson & Johnson Services Antibodies Product Portfolio
        6.3.5 Johnson & Johnson Services Recent Developments/Updates
    6.4 Amgen
        6.4.1 Amgen Corporation Information
        6.4.2 Amgen Description and Business Overview
        6.4.3 Amgen Antibodies Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Amgen Antibodies Product Portfolio
        6.4.5 Amgen Recent Developments/Updates
    6.5 Bristol-Myers Squibb
        6.5.1 Bristol-Myers Squibb Corporation Information
        6.5.2 Bristol-Myers Squibb Description and Business Overview
        6.5.3 Bristol-Myers Squibb Antibodies Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Bristol-Myers Squibb Antibodies Product Portfolio
        6.5.5 Bristol-Myers Squibb Recent Developments/Updates
    6.6 AbbVie
        6.6.1 AbbVie Corporation Information
        6.6.2 AbbVie Description and Business Overview
        6.6.3 AbbVie Antibodies Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 AbbVie Antibodies Product Portfolio
        6.6.5 AbbVie Recent Developments/Updates
    6.7 Eli Lilly
        6.6.1 Eli Lilly Corporation Information
        6.6.2 Eli Lilly Description and Business Overview
        6.6.3 Eli Lilly Antibodies Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Eli Lilly Antibodies Product Portfolio
        6.7.5 Eli Lilly Recent Developments/Updates
7 Antibodies Manufacturing Cost Analysis
    7.1 Antibodies Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Antibodies
    7.4 Antibodies Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Antibodies Distributors List
    8.3 Antibodies Customers
9 Antibodies Market Dynamics
    9.1 Antibodies Industry Trends
    9.2 Antibodies Market Drivers
    9.3 Antibodies Market Challenges
    9.4 Antibodies Market Restraints
10 Global Market Forecast
    10.1 Antibodies Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Antibodies by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Antibodies by Type (2023-2028)
    10.2 Antibodies Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Antibodies by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Antibodies by Application (2023-2028)
    10.3 Antibodies Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Antibodies by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Antibodies by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Antibodies Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Antibodies Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Antibodies Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Antibodies Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Antibodies Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Antibodies Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Antibodies Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Antibodies Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Antibodies Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Antibodies Manufacturing Sites and Area Served
    Table 11. Manufacturers Antibodies Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibodies as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Antibodies Sales by Region (2017-2022) & (K Units)
    Table 16. Global Antibodies Sales Market Share by Region (2017-2022)
    Table 17. Global Antibodies Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Antibodies Revenue Market Share by Region (2017-2022)
    Table 19. North America Antibodies Sales by Country (2017-2022) & (K Units)
    Table 20. North America Antibodies Sales Market Share by Country (2017-2022)
    Table 21. North America Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Antibodies Revenue Market Share by Country (2017-2022)
    Table 23. Europe Antibodies Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Antibodies Sales Market Share by Country (2017-2022)
    Table 25. Europe Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Antibodies Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Antibodies Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Antibodies Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Antibodies Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Antibodies Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Antibodies Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Antibodies Sales Market Share by Country (2017-2022)
    Table 33. Latin America Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Antibodies Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Antibodies Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Antibodies Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Antibodies Revenue Market Share by Country (2017-2022)
    Table 39. Global Antibodies Sales by Type (2017-2022) & (K Units)
    Table 40. Global Antibodies Sales Market Share by Type (2017-2022)
    Table 41. Global Antibodies Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Antibodies Revenue Share by Type (2017-2022)
    Table 43. Global Antibodies Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Antibodies Sales (K Units) by Application (2017-2022)
    Table 45. Global Antibodies Sales Market Share by Application (2017-2022)
    Table 46. Global Antibodies Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Antibodies Revenue Share by Application (2017-2022)
    Table 48. Global Antibodies Price by Application (2017-2022) & (USD/Unit)
    Table 49. Novartis Corporation Information
    Table 50. Novartis Description and Business Overview
    Table 51. Novartis Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Novartis Antibodies Product
    Table 53. Novartis Recent Developments/Updates
    Table 54. F. Hoffmann-La Roche Corporation Information
    Table 55. F. Hoffmann-La Roche Description and Business Overview
    Table 56. F. Hoffmann-La Roche Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. F. Hoffmann-La Roche Antibodies Product
    Table 58. F. Hoffmann-La Roche Recent Developments/Updates
    Table 59. Johnson & Johnson Services Corporation Information
    Table 60. Johnson & Johnson Services Description and Business Overview
    Table 61. Johnson & Johnson Services Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Johnson & Johnson Services Antibodies Product
    Table 63. Johnson & Johnson Services Recent Developments/Updates
    Table 64. Amgen Corporation Information
    Table 65. Amgen Description and Business Overview
    Table 66. Amgen Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Amgen Antibodies Product
    Table 68. Amgen Recent Developments/Updates
    Table 69. Bristol-Myers Squibb Corporation Information
    Table 70. Bristol-Myers Squibb Description and Business Overview
    Table 71. Bristol-Myers Squibb Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Bristol-Myers Squibb Antibodies Product
    Table 73. Bristol-Myers Squibb Recent Developments/Updates
    Table 74. AbbVie Corporation Information
    Table 75. AbbVie Description and Business Overview
    Table 76. AbbVie Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. AbbVie Antibodies Product
    Table 78. AbbVie Recent Developments/Updates
    Table 79. Eli Lilly Corporation Information
    Table 80. Eli Lilly Description and Business Overview
    Table 81. Eli Lilly Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Eli Lilly Antibodies Product
    Table 83. Eli Lilly Recent Developments/Updates
    Table 84. Production Base and Market Concentration Rate of Raw Material
    Table 85. Key Suppliers of Raw Materials
    Table 86. Antibodies Distributors List
    Table 87. Antibodies Customers List
    Table 88. Antibodies Market Trends
    Table 89. Antibodies Market Drivers
    Table 90. Antibodies Market Challenges
    Table 91. Antibodies Market Restraints
    Table 92. Global Antibodies Sales Forecast by Type (2023-2028) & (K Units)
    Table 93. Global Antibodies Sales Market Share Forecast by Type (2023-2028)
    Table 94. Global Antibodies Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 95. Global Antibodies Revenue Market Share Forecast by Type (2023-2028)
    Table 96. Global Antibodies Sales Forecast by Application (2023-2028) & (K Units)
    Table 97. Global Antibodies Sales Market Share Forecast by Application (2023-2028)
    Table 98. Global Antibodies Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 99. Global Antibodies Revenue Market Share Forecast by Application (2023-2028)
    Table 100. Global Antibodies Sales Forecast by Region (2023-2028) & (K Units)
    Table 101. Global Antibodies Sales Market Share Forecast by Region (2023-2028)
    Table 102. Global Antibodies Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 103. Global Antibodies Revenue Market Share Forecast by Region (2023-2028)
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Antibodies
    Figure 2. Global Antibodies Market Share by Type in 2021 & 2028
    Figure 3. Monoclonal antibodies Product Picture
    Figure 4. Polyclonal antibodies Product Picture
    Figure 5. Antibody drug conjugates Product Picture
    Figure 6. Global Antibodies Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Long-term care facilities
    Figure 9. Research institutes
    Figure 10. Global Antibodies Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Antibodies Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Antibodies Sales (2017-2028) & (K Units)
    Figure 13. Antibodies Sales Share by Manufacturers in 2021
    Figure 14. Global Antibodies Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Antibodies Players: Market Share by Revenue in 2021
    Figure 16. Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Antibodies Sales Market Share by Region (2017-2022)
    Figure 18. Global Antibodies Sales Market Share by Region in 2021
    Figure 19. Global Antibodies Revenue Market Share by Region (2017-2022)
    Figure 20. Global Antibodies Revenue Market Share by Region in 2021
    Figure 21. U.S. Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Taiwan Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Philippines Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Vietnam Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Mexico Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Brazil Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Argentina Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE Antibodies Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Antibodies by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Antibodies
    Figure 47. Manufacturing Process Analysis of Antibodies
    Figure 48. Antibodies Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
F. Hoffmann-La Roche
Johnson & Johnson Services
Amgen
Bristol-Myers Squibb
AbbVie
Eli Lilly
Frequently Asked Questions
Antibodies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antibodies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antibodies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Apple Accessories

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More